Cordex
Pharma Inc., Philadelphia, PA October. 2007 to Present
CEO Jan 2010 to Present
Board Director, Audit Chairman Oct. 2007 to Present
Specialty
pharmaceutical company developing new cardiovascular medicines based
upon the emerging new pharmacology of adenosine 5'-triphosphate (ATP)
and nitric oxide (NO). These two molecules play critical roles in
cellular metabolism and signal transduction, the manipulation of which
by several pharmaceuticals constitute novel therapeutic modalities for
the treatment of major cardiovascular disorders.